Aquarius uses a drug delivery technology to allow oral delivery of drugs that are now only available via IV, and reduce drug toxicity.
Many drugs exist that are effective in treating diseases, but are difficult and expensive to administer with existing technology. In addition, many of these drugs are highly toxic and have a short shelf-life. Aquarius' technology, called "cochleate" technology, solves these problems by delivering the drugs more cheaply and effectively with less toxicity. Aquarius partners with pharma and biotech companies to develop drugs using the technology.